Paradigm Capital Management Inc. NY purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 738,400 shares of the company’s stock, valued at approximately $17,079,000.
A number of other institutional investors have also recently bought and sold shares of the business. Global Retirement Partners LLC bought a new stake in Bath & Body Works in the fourth quarter valued at approximately $31,000. Activest Wealth Management bought a new position in shares of Bath & Body Works during the 4th quarter worth approximately $32,000. Geneos Wealth Management Inc. boosted its stake in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC increased its holdings in shares of Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the last quarter. Finally, Danske Bank A S acquired a new position in shares of Bath & Body Works during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.
Analyst Upgrades and Downgrades
BBWI has been the subject of several research reports. UBS Group reaffirmed a “neutral” rating on shares of Bath & Body Works in a report on Wednesday, August 19th. Wells Fargo & Company upped their price objective on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Tuesday, June 23rd. Telsey Advisory Group dropped their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research report on Thursday, May 28th. TD Cowen increased their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Finally, Barclays cut their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, May 28th. Four equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $22.57.
Bath & Body Works Stock Down 1.5%
Shares of NYSE:BBWI opened at $19.16 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $32.32. The company’s 50 day moving average price is $20.46 and its two-hundred day moving average price is $20.06. The firm has a market cap of $3.86 billion, a PE ratio of 5.38, a PEG ratio of 1.92 and a beta of 1.38.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 2.63 EPS for the current year.
Bath & Body Works Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.2%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s dividend payout ratio is 22.47%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
